Search - tctmd.com

Displaying 601 - 620 of 638

Sort: Relevancy | Date

News Conference News

Experts Remain Hopeful for the Future of Interventional Innovation

November 06, 2011

News Industry News

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

November 04, 2011

News Industry News

ACC, CRF Announce Enhancements to Educational Collaboration

November 04, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

November 02, 2011

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Industry News

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

November 01, 2011

News Daily News

CRF, ACC Partnership Enhances Interventional Education, Science Worldwide

October 31, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Industry News

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

September 08, 2011

News Industry News

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

August 16, 2011

News Daily News

NEJM Articles Argue to Sack FDA’s Device Clearance Process

Caitlin E. Cox

August 12, 2011

News Industry News

Boston Scientific's WallFlex® Biliary RX Stent Receives Canadian Approval for Expanded Indication

August 09, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Commentary Authors Urge Improvements to Device Approval Process

Caitlin E. Cox

July 20, 2011

News Industry News

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

May 24, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Industry News

Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR

May 16, 2011

News Industry News

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

May 12, 2011

News Industry News

Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death

May 06, 2011

Advertisement

Experts Remain Hopeful for the Future of Interventional Innovation

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

ACC, CRF Announce Enhancements to Educational Collaboration

Abbott to Present New Data for Key Vascular Products at TCT 2011

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

CRF, ACC Partnership Enhances Interventional Education, Science Worldwide

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

NEJM Articles Argue to Sack FDA’s Device Clearance Process

Boston Scientific's WallFlex® Biliary RX Stent Receives Canadian Approval for Expanded Indication

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Commentary Authors Urge Improvements to Device Approval Process

Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR

Data From Multiple Clinical Trials of OrbusNeich's GenousTM Stent Set for Presentation at EuroPCR 2011

Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content